Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREBOT-II Trial
DRKS00024061Phase 2Completed
- Sponsor
- Heidelberg University
- Start
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in Bile duct fistula (BDF), Bile duct perforation (BDP) and Bile leak (2 arms), sponsored by Heidelberg University. Started Oct 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Bile duct fistula (BDF)Bile duct perforation (BDP)Bile leak
Beyond the preview
Go deeper on DRKS00024061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00024061.